Novartis expects the new capacity will allow it to produce all of its key medicines “end to end” in the U.S., as the Trump administration buffets global trade with tariffs.
Categories:
Related Post
Gilbane, F.A. Wilhelm top out $4.3B Indianapolis hospital
The project, which will feature 864 inpatient rooms and 50 operating rooms, has ballooned in…
White House unveils plan for tech-focused permit reforms
The initiative follows a recent Supreme Court ruling that narrowed the scope of environmental reviews…
Minneapolis Fed survey: Nonresidential builders face tighter pipelines, rising costs
“Uncertainty isn’t going away quickly,” an official said, but data centers and healthcare projects are…